dengue fever

(redirected from Dengue hemorrhagic fever)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms.
Related to Dengue hemorrhagic fever: Dengue Shock Syndrome

dengue fever

(dĕng`gē, –gā), acute infectious disease caused by four closely related viruses and transmitted by the bite of the female Aedes mosquito; it is also known as breakbone fever and bone-crusher disease. The disease occurs in both epidemic and sporadic form in warm climates (S United States, South America, the E Mediterranean countries, India, and especially SE Asia and the W Pacific). The classic symptoms, following an incubation period of five to eight days, are high fever, chills, severe headache, pain in the joints, pain behind the eyes, rash, sweating, and prostration, but infected persons may experience milder symptoms. Symptoms subside in two to four days, but after a remission lasting from a few hours to two days there is another rise in temperature, and a generalized rash appears. Convalescence is sometimes prolonged, with weakness and low blood pressure.

Dengue hemorrhagic fever, a severe form of the disease, can cause hemorrhage, shock, and encephalitis. It can occur when a person who has acquired immunity to one of the viruses that cause dengue fever is infected by a different dengue virus; antibodies to the first dengue infection apparently work to aid the second virus. It is a leading cause of death among children in Southeast Asia and in recent years has become increasingly prevalent in tropical America. There is no specific treatment for dengue fever except good nursing care. Both diseases can be controlled by eradicating the mosquitoes and destroying their breeding places; the mosquito population also has been controlled through the release of sterile male mosquitoes.

Dengue fever

[′deŋ·gē ‚fēv·ər]
An infection borne by the Aedes female mosquito, and caused by one of four closely related but antigenically distinct Dengue virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4). It starts abruptly after an incubation period of 2-7 days with high fever, severe headache, myalgia, and rash. It is found throughout the tropical and subtropical zones. Also known as break-bone fever.
References in periodicals archive ?
Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore.
Dengue hemorrhagic fever in the state of Rio de Janeiro, Brazil: a study of 56 confirmed cases.
Clinical characteristics of dengue and dengue hemorrhagic fever in a medical centre of southern Taiwan during the 2002 epidemic.
Hemophagocytic syndrome in Dengue hemorrhagic fever with severe multiorgan complications.
A low platelet count and increased hematocrit indicate increased likelihood that a patient will develop dengue hemorrhagic fever or shock syndrome.
The authors urged health authorities along the border to consider strengthening dengue surveillance and for local health providers to be trained to recognize and manage dengue hemorrhagic fever.
Dengue hemorrhagic fever includes those symptoms plus small-blood vessel leakage, which can lead to shock, internal bleeding, circulatory failure, and death.
Patients should receive supportive treatment, with only acetaminophen for pain and fever, and should be monitored for dengue hemorrhagic fever with provision of fluids as necessary; according to the CDC.
Cangene also recently began a trial investigating the use of WinRho(R)SDF for treating dengue hemorrhagic fever.
One form, dengue hemorrhagic fever, is fatal in about five percent of patients.
In most cases, the body's natural resistance can defeat the "classical" dengue virus, but dengue hemorrhagic fever victims often die.